Home » Topics » BioWorld Science

BioWorld Science
RSS

Recombinant Dodekin has anticancer activity alone or with checkpoint inhibitors

May 15, 2018

New KDM1A inhibitors developed by Constellation Pharmaceuticals

May 15, 2018

Pfenex reports topline results from study of PF-708 in osteoporosis

May 15, 2018

Interpace to launch new thyroid test ThyGeNEXT

May 15, 2018

Chinese researchers divulge Trk inhibitors

May 15, 2018

Nimbus Lakshmi patents TYK2 inhibitors

May 15, 2018

NanoViricides confirms progress in HerpeCide program

May 15, 2018

FDA approves subcutaneous Actemra for active polyarticular juvenile idiopathic arthritis

May 15, 2018

Zymeworks and Daiichi Sankyo expand immuno-oncology collaboration

May 15, 2018

Medisix Therapeutics closes series A financing

May 15, 2018

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...